Metabolism of halothane was studied in nine children receiving daily halothane anaesthetics (from 10 up to a maximum of 31) over periods of two to seven weeks. Serum bromide concentrations never exceeded 3.5 mmol/l, a concentration below the toxic threshold. Repeated halothane anaesthetics at short intervals did not induce the reductive metabolism of halothane as assessed by 2-chloro-1,1,1-trifluoroethane (CTF) in the expired breath. One patient developed viral hepatitis A during the course of anaesthetic administration; this patient was the only one whose serum bromide concentrations fell substantially and whose exhaled CTF concentration increased as more anaesthetics were administered.
InmanWHW, MushinWW. Jaundice after repeated exposure to halothane: An analysis of reports to the Committee on Safety of Medicines. Br Med J1974; 1:5–10.
2.
PlummerJL, CousinsMJ, HallP.Volatile anaesthetic metabolism and acute toxicity. Rev Drug Metab Drug Interact1982; 4:49–98.
3.
SipesIG, GandolfiAJ. Role of reactive intermediates in halothane-associated liver injury. In: Biological Reactive Intermediates. II, Part 1, SnyderR, ParkeDV, KocsisJJ, JollowDJ, GibsonCG, WitmerCM, eds. Plenum Publishing Corp1983; 603–608.
4.
RietbrockI, LazarusG, OtterbeinA.Effect of halothane on the hepatic drug metabolising system. Arch Pharmacol1972; 273:422–426.
5.
PlummerJL, HallP, JennerMA, IlsleyAH, CousinsMJ. Effects of chronic inhalation of halothane, enflurane or isoflurane in rats. Br J Anaesth1986; 58:517–523.
6.
DuvaldestinP, MazzeRI, NivocheY, DesmontsJ-M.Occupational exposure to halothane results in enzyme induction in anesthetists. Anesthesiology1981; 54:57–60.
HaxholdtO St, LoftS, ClemmensenA, HjortsoE.Increased hepatic microsomal activity after halothane anaesthesia in children. Anaesthesia1986; 41:579–581.
9.
WarkHJ. Postoperative jaundice in children. The influence of halothane. Anaesthesia1983; 38:237–242.
10.
AllenTH. Multiple halothane anaesthetics for intravenous therapy in children. Anaesth Intens Care1977; 5:179–180.
11.
PratilasV, PratilaMG. Multiple halothane anesthesias in a child: A case report. Mt Sinai J Med1978; 45:480–483.
12.
TinkerJH, GandolfiAJ, Van DykeRA. Elevation of plasma bromide levels in patients following halothane anesthesia: Time correlation with total halothane dosage. Anesthesiology1976; 44:194–196.
13.
BarbourRF. Bromide intoxication. Proc Roy Soc Med1936; 29:1391–1396.
14.
DuvaldestinP, MazzeRI, NovocheY, DesmontsJ-M.Can the extent of halothane debromination be predicted preoperatively?Anesth Analg1979; 58:470–474.
15.
GaffG, RandMJ, DiamondJ.A rapid screening test for bromism. Med J Aust1969; 1:967–969.
16.
CousinsMJ, SharpJH, GourlayGK, AdamsJF, HaynesWD, WhiteheadR.Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesth Intens Care1979; 7:9–24.
17.
LehmannEL. Nonparametrics: Statistical methods based on ranks. McGraw-Hill International Book Company, New York, 1975; 290–297.
18.
SimpsonBR, StruninL, WaltonB.Evidence for halothane hepatotoxicity is equivocal. In: Controversy in Internal Medicine II. IngelfingerFJ, EbertRV, FinlandM, RelmanAS, eds. W. B. Saunders Co., Philadelphia, 1974; 580–594.
19.
SharpJH, TrudellJR, CohenEN. Volatile metabolites and decomposition products of halothane in man. Anesthesiology1979; 50:2–8.
20.
GourlayGK, AdamsJF, CousinsMJ, SharpJH. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model. Br J Anaesth1980; 52:331–336.
21.
PlummerJL, CousinsMJ, HallP.Hypoxia and halothane hepatotoxicity. Anesth Analg1983; 62:859.
